Piontkewitz Y, Enerbäck S, Hedin L
Department of Physiology, University of Goteborg, Sweden.
Endocrinology. 1993 Nov;133(5):2327-33. doi: 10.1210/endo.133.5.8404685.
Follicular development involves both proliferation and differentiation of thecal and granulosa cells. The process is regulated by gonadotropins and paracrine and autocrine factors, including steroid hormones, presumably by the induction of different genes at specific time points. In the present study, the expression and distribution of the CCAAT enhancer-binding protein-alpha (C/EBP alpha) were studied in immature ovaries and in ovaries in which follicular growth and development were initiated with PMSG, whereas ovulation and luteal formation were induced by the injection of hCG. Ovaries were collected before and at different time points after PMSG (0, 6, 24, and 48 h) and hCG (0.25, 1, 3, 10, and 24 h) treatment for analyses of the contents of C/EBP alpha mRNA and protein and the cell-specific immunohistochemical localization of the protein. C/EBP alpha mRNA increased to maximal levels 24 h after PMSG treatment. The effect was specific for the ovary, as C/EBP alpha mRNA in the uterus did not change. C/EBP alpha mRNA decreased 10 h after hCG treatment and increased again in newly formed corpora lutea. Immunohistochemistry and immunoblotting demonstrated a similar increase in C/EBP alpha during follicular development. To examine the involvement of specific hormones in the regulation of C/EBP alpha, hypophysectomized immature rats were injected sequentially with estradiol and FSH. This treatment resulted in a substantial increase in C/EBP alpha mRNA and protein. These results demonstrate that C/EBP alpha is hormonally regulated in the ovary and suggest a role for C/EBP alpha during differentiation of ovarian cells and follicular development.
卵泡发育涉及卵泡膜细胞和颗粒细胞的增殖与分化。该过程受促性腺激素以及旁分泌和自分泌因子(包括甾体激素)的调节,可能是通过在特定时间点诱导不同基因来实现的。在本研究中,我们研究了CCAAT增强子结合蛋白α(C/EBPα)在未成熟卵巢以及用孕马血清促性腺激素(PMSG)启动卵泡生长和发育、随后注射人绒毛膜促性腺激素(hCG)诱导排卵和黄体形成的卵巢中的表达和分布。在PMSG(0、6、24和48小时)和hCG(0.25、1、3、10和24小时)处理前及不同时间点收集卵巢,以分析C/EBPα mRNA和蛋白的含量以及该蛋白的细胞特异性免疫组化定位。PMSG处理后24小时,C/EBPα mRNA增加至最高水平。这种效应是卵巢特异性的,因为子宫中的C/EBPα mRNA没有变化。hCG处理后10小时,C/EBPα mRNA下降,而在新形成的黄体中再次升高。免疫组化和免疫印迹显示在卵泡发育过程中C/EBPα有类似的增加。为了研究特定激素在C/EBPα调节中的作用,对未成熟的垂体切除大鼠依次注射雌二醇和促卵泡素(FSH)。这种处理导致C/EBPα mRNA和蛋白大量增加。这些结果表明,C/EBPα在卵巢中受激素调节,并提示C/EBPα在卵巢细胞分化和卵泡发育过程中发挥作用。